Guidelines: is bigger better? A review of SIGN guidelines

被引:23
作者
Baird, A. Gordon [1 ]
Lawrence, James R. [1 ]
机构
[1] Dumfries & Galloway Royal Infirm, Res & Dev Support Unit, Dumfries, Scotland
来源
BMJ OPEN | 2014年 / 4卷 / 02期
关键词
Health Services Administration & Management; CLINICAL GUIDELINES; RECOMMENDATIONS; NETWORK;
D O I
10.1136/bmjopen-2013-004278
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives To quantify and analyse the quality of evidence that is presented in national guidelines. Setting Levels of evidence used in all the current valid recommendations in the Scottish Intercollegiate Guideline Network (SIGN) guidelines were reviewed and statistically analysed. Outcome measures The proportion of level D evidence used in each guideline and a statistical analysis. Method Data were collected from published guidelines available online to the public. SIGN methodology entails a professional group selected by a national organisation to develop each of these guidelines. Statistical analysis of the relationship between the number of guideline recommendations and the quality of evidence used in its recommendations was performed. Result The proportion of level D evidence increases with the number of recommendations made. This correlation is significant with Kendall's =0.22 (approximate 95% CI 0.008 to 0.45), p=0.04; and Spearman =0.22 (approximate 95% CI 0.02 to 0.57), p=0.04. Conclusions Practice guidelines should be brief and based on scientific evidence. Paradoxically the longest guidelines have the highest proportion of recommendations based on the lowest level of evidence. Guideline developers should be more aware of the need for brevity and a stricter application of evidence-based principles could achieve this. The findings support calls for a review of how evidence is used and presented in guidelines.
引用
收藏
页数:5
相关论文
共 27 条
  • [1] Anderson JE, 2012, ASS COL GREAT BRIT I
  • [2] [Anonymous], 2006, CLIN GUIDELINE PROGR
  • [3] Atkins D, 2004, BMJ-BRIT MED J, V328, P1490
  • [4] Personal View Do geriatricians need guidelines?
    Aylett, Virginia
    [J]. BRITISH MEDICAL JOURNAL, 2010, 341 : c5340
  • [5] Caplan Louis R, 2007, Rev Neurol Dis, V4, P75
  • [6] Drug Regulation Rosiglitazone: what went wrong?
    Cohen, Deborah
    [J]. BRITISH MEDICAL JOURNAL, 2010, 341 : 530 - 535
  • [7] MORTALITY AND MORBIDITY IN PATIENTS RECEIVING ENCAINIDE, FLECAINIDE, OR PLACEBO - THE CARDIAC-ARRHYTHMIA SUPPRESSION TRIAL
    ECHT, DS
    LIEBSON, PR
    MITCHELL, LB
    PETERS, RW
    OBIASMANNO, D
    BARKER, AH
    ARENSBERG, D
    BAKER, A
    FRIEDMAN, L
    GREENE, HL
    HUTHER, ML
    RICHARDSON, DW
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (12) : 781 - 788
  • [8] Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743
  • [9] Greenhalgh T, 2010, READ PAPER BASICS EV, P1
  • [10] Who writes guidelines, and who should?
    Guy, S
    Wardlaw, JM
    [J]. CLINICAL RADIOLOGY, 2002, 57 (10) : 891 - 897